What does CUSIP 457637502 represent in this 13F holders report?

CUSIP 457637502 is the security identifier for INM - InMed Pharmaceuticals Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held INM - InMed Pharmaceuticals Inc. - Common Stock in Q2 2021?

11 institutional investors reported INM - InMed Pharmaceuticals Inc. - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

InMed Pharmaceuticals Inc. - Common Stock (INM)

CUSIP: 457637502

Q2 2021 13F Holders as of 30 Jun 2021

Security type / class: Equity / Common Stock
Total 13F shares: 943,601
Total 13F value: $2,986,625
Share change: +485,570
SEC-reported price per share: $3.18
Number of holders: 11
Value change: +$1,515,757
Number of buys: 4
Number of sells: 5
Shares outstanding: 737,449

Security key

457637502

Report period

Q2 2021

Institutions

Top holders

INM full security history Ownership snapshot Full 13F holder table InMed Pharmaceuticals Inc. SEC filings InMed Pharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of INM - InMed Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

0/15

Latest evidence

31 Mar 2021

13F Highest disclosed value: $776,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $776K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Disclosed position value Top 5

ARMISTICE CAPITAL, LLC $776K

Hudson Bay Capital Management LP $531K

CITADEL ADVISORS LLC $57K

BANK OF AMERICA CORP /DE/ $53K

MORGAN STANLEY $41K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$776,000 235,000 shares	—	31 Mar 2021
Hudson Bay Capital Management LP	13F Company 13F	— denominator unverified	$531,000 161,000 shares	—	31 Mar 2021
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$57,000 17,211 shares	—	31 Mar 2021
BANK OF AMERICA CORP /DE/	13F Company 13F	— denominator unverified	$53,000 16,120 shares	—	31 Mar 2021
MORGAN STANLEY	13F Company 13F	— denominator unverified	$41,000 12,581 shares	—	31 Mar 2021
Creative Planning	13F Company 13F	— denominator unverified	$36,000 10,990 shares	—	31 Mar 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

943,601

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

-1

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 value	Q2 2021 value	Value change	Value Chg %